Can-Fite BioPharma (NYSE:CANF) Coverage Initiated at StockNews.com
StockNews.com started coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the stock. Several other analysts also recently issued reports on the company. D. Boral Capital restated a “buy” rating and issued a $10.00 price objective on […]
More Stories
Southern Poverty Law Center Charged With Fraud Over Payments to Informants in Extremist Groups
By Tom Gantert The Southern Poverty Law Center was indicted on federal fraud charges that accused it of illegally raising...
Dr. Oz Says Anti-Fraud Effort Coming to ‘All 50 States’
By Jack Phillips Dr. Mehmet Oz, the administrator of the agency overseeing Medicaid and Medicare, announced Tuesday that his agency’s...
US Retail Sales Jump in March as Higher Gas Prices Lift Spending
By Bill Pan Americans kept on spending in March amid a sharp rise in gasoline prices, new government data suggest....
Trump Announces Extension of Iran Ceasefire
By Jack Phillips President Donald Trump on Tuesday announced he is extending a ceasefire with Iran, citing what he said...
Democratic Rep. Cherfilus-McCormick Resigns Ahead of Ethics Committee Sanctions Hearing
By Chase Smith Rep. Sheila Cherfilus-McCormick (D-Fla.) resigned from Congress on Tuesday, stepping down hours before the House Ethics Committee...
Is Hell’s Paradise Season 3 Renewed? Release Date, Plot, and Episodes
With the recent release of the anime series Hell’s Paradise, fans are curious to know about the renewal status of...